Product image of Norditropin Simplexx (Somatropin) supplied by GNH India

Norditropin Simplexx

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Simplexx (Somatropin)

Somatropin, the active ingredient in Norditropin Simplexx, is a human growth hormone presented as a subcutaneous injection for subcutaneous administration. It is indicated for patients with growth hormone deficiency and several genetic or chronic conditions that impair normal growth, helping to stimulate linear growth and improve body composition.

GNH India supplies Norditropin Simplexx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for qualified healthcare providers and ensuring product integrity throughout the supply chain.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Simplexx (somatropin) is used in endocrine and genetic disorders that affect growth.

  • Growth hormone deficiency: restores normal growth velocity and improves body composition.
  • Turner syndrome: promotes linear growth in affected females.
  • Chronic renal insufficiency: supports growth in children with renal disease.
  • Prader‑Willi syndrome: enhances growth and body composition.
  • Idiopathic short stature: increases height potential in children with unexplained short stature.

How It Works

  • Somatropin binds to growth‑hormone receptors on target cells, activating the JAK2‑STAT5 signaling cascade. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and downstream mediators, leading to increased protein synthesis, cartilage proliferation, and lipolysis, which collectively promote linear bone growth, muscle mass accrual, and metabolic effects.

Side Effects

Somatropin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Injection site pain: mild discomfort or erythema.
  • Headache: transient episodes.
  • Joint stiffness: occasional stiffness.
  • Edema: mild peripheral swelling.

Serious or Rare Side Effects

  • Intracranial hypertension: signs of increased intracranial pressure.
  • Slipped capital femoral epiphysis: hip pain with limited motion.
  • Severe allergic reaction: rash, urticaria, or anaphylaxis.

Precautions & Warnings

When prescribing somatropin, clinicians should consider several precautionary measures to ensure safe use.

  • Monitor IGF‑1 levels: adjust dose based on serum IGF‑1 concentrations.
  • Screen for intracranial hypertension: assess for headache, visual changes, or papilledema.
  • Evaluate glucose metabolism: watch for hyperglycemia or diabetes.
  • Assess for tumor history: avoid in active malignancy.
  • Pediatric growth monitoring: regularly measure height and growth velocity.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Glucocorticoids: may antagonize growth‑promoting effects.
  • Antidiabetic agents: increased risk of hyperglycemia may require dose adjustment.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: may need monitoring of thyroid status.
  • Estrogen therapy: can affect IGF‑1 levels.
  • CYP enzyme inducers: potential impact on somatropin metabolism is minimal but clinical observation advised.

Frequently Asked Questions

Norditropin Simplexx contains somatropin, a recombinant human growth hormone used to treat growth hormone deficiency and several conditions that impair normal growth, such as Turner syndrome, chronic renal insufficiency, Prader‑Willi syndrome, and idiopathic short stature.

Somatropin binds to growth‑hormone receptors, triggering intracellular signaling that increases hepatic production of insulin‑like growth factor‑1 (IGF‑1). The rise in IGF‑1 promotes bone growth, protein synthesis, and metabolic effects that support linear growth and body‑composition changes.

The dose of Norditropin Simplexx is individualized. A qualified prescriber determines the appropriate amount and frequency based on the patient’s age, weight, IGF‑1 levels, and specific clinical indication.

Safety of somatropin during pregnancy or lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and only under medical supervision.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Norditropin Simplexx is a recombinant somatropin similar in efficacy to other approved growth‑hormone brands. Differences may lie in the delivery device, formulation stability, and packaging, but the active molecule and clinical outcomes are comparable when used as directed.

The product must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep it in the original carton until use to maintain potency.

Norditropin Simplexx is given by subcutaneous injection, typically into the thigh, abdomen, or upper arm. The injection site should be rotated with each dose, and the technique should follow the prescriber’s instructions or the product’s administration guide.

Serious risks include intracranial hypertension, slipped capital femoral epiphysis, severe allergic reactions (including anaphylaxis), and possible acceleration of tumor growth in patients with active malignancy. Prompt medical evaluation is required if any of these occur.

Patients with known hypersensitivity to somatropin or any excipients, those with active malignancy, or individuals with uncontrolled diabetes should avoid using Norditropin Simplexx unless a specialist determines that benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT